Detalhe da pesquisa
1.
Nelarabine, etoposide, and cyclophosphamide in relapsed pediatric T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma (study T2008-002 NECTAR).
Pediatr Blood Cancer
; 69(11): e29901, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35989458
2.
A phase I study of EZN-3042, a novel survivin messenger ribonucleic acid (mRNA) antagonist, administered in combination with chemotherapy in children with relapsed acute lymphoblastic leukemia (ALL): a report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium.
J Pediatr Hematol Oncol
; 36(6): 458-63, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24276047
3.
A Phase I Study of Quizartinib Combined with Chemotherapy in Relapsed Childhood Leukemia: A Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study.
Clin Cancer Res
; 22(16): 4014-22, 2016 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26920889